These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 28847478
1. Pharmacologically Safe Nanomicelles of Amphotericin B With Lipids: Nuclear Magnetic Resonance and Molecular Docking Approach. Usman F, Ul-Haq Z, Khalil R, Tinpun K, Srichana T. J Pharm Sci; 2017 Dec; 106(12):3574-3582. PubMed ID: 28847478 [Abstract] [Full Text] [Related]
2. Bioactivity, Safety, and Efficacy of Amphotericin B Nanomicellar Aerosols Using Sodium Deoxycholate Sulfate as the Lipid Carrier. Usman F, Khalil R, Ul-Haq Z, Nakpheng T, Srichana T. AAPS PharmSciTech; 2018 Jul; 19(5):2077-2086. PubMed ID: 29691753 [Abstract] [Full Text] [Related]
3. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation. Gangadhar KN, Adhikari K, Srichana T. Int J Pharm; 2014 Aug 25; 471(1-2):430-8. PubMed ID: 24907597 [Abstract] [Full Text] [Related]
4. Biodistribution and histopathology studies of amphotericin B sodium deoxycholate sulfate formulation following intratracheal instillation in rat models. Usman F, Nopparat J, Javed I, Srichana T. Drug Deliv Transl Res; 2020 Feb 25; 10(1):59-69. PubMed ID: 31368043 [Abstract] [Full Text] [Related]
5. Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B. Alvarez C, Shin DH, Kwon GS. Pharm Res; 2016 Sep 25; 33(9):2098-106. PubMed ID: 27198671 [Abstract] [Full Text] [Related]
6. Biodegradable functional polycarbonate micelles for controlled release of amphotericin B. Wang Y, Ke X, Voo ZX, Yap SSL, Yang C, Gao S, Liu S, Venkataraman S, Obuobi SAO, Khara JS, Yang YY, Ee PLR. Acta Biomater; 2016 Dec 25; 46():211-220. PubMed ID: 27686042 [Abstract] [Full Text] [Related]
7. Lipoamino acid-based micelles as promising delivery vehicles for monomeric amphotericin B. Serafim C, Ferreira I, Rijo P, Pinheiro L, Faustino C, Calado A, Garcia-Rio L. Int J Pharm; 2016 Jan 30; 497(1-2):23-35. PubMed ID: 26617315 [Abstract] [Full Text] [Related]
8. Amphotericin B loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): physicochemical and solid-solution state characterizations. Jansook P, Fülöp Z, Ritthidej GC. Drug Dev Ind Pharm; 2019 Apr 30; 45(4):560-567. PubMed ID: 30632399 [Abstract] [Full Text] [Related]
9. Amphotericin B Loaded Nanostructured Lipid Carriers for Parenteral Delivery: Characterization, Antifungal and In vitro Toxicity Assessment. Nimtrakul P, Tiyaboonchai W, Lamlertthon S. Curr Drug Deliv; 2019 Apr 30; 16(7):645-653. PubMed ID: 31362675 [Abstract] [Full Text] [Related]
10. Efficacy and toxicity evaluation of new amphotericin B micelle systems for brain fungal infections. Moreno-Rodríguez AC, Torrado-Durán S, Molero G, García-Rodríguez JJ, Torrado-Santiago S. Int J Pharm; 2015 Oct 15; 494(1):17-22. PubMed ID: 26256151 [Abstract] [Full Text] [Related]
11. Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B. Jain S, Valvi PU, Swarnakar NK, Thanki K. Mol Pharm; 2012 Sep 04; 9(9):2542-53. PubMed ID: 22845020 [Abstract] [Full Text] [Related]
12. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B. Hussain A, Singh VK, Singh OP, Shafaat K, Kumar S, Ahmad FJ. Drug Deliv; 2016 Oct 04; 23(8):3101-3110. PubMed ID: 27854145 [Abstract] [Full Text] [Related]
13. Amphotericin B-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): effect of drug loading and biopharmaceutical characterizations. Jansook P, Pichayakorn W, Ritthidej GC. Drug Dev Ind Pharm; 2018 Oct 04; 44(10):1693-1700. PubMed ID: 29936874 [Abstract] [Full Text] [Related]
14. Biochemical characterization of GM1 micelles-Amphotericin B interaction. Leonhard V, Alasino RV, Bianco ID, Garro AG, Heredia V, Beltramo DM. Curr Drug Deliv; 2015 Oct 04; 12(4):406-14. PubMed ID: 25772153 [Abstract] [Full Text] [Related]
15. Binding interactions of bacterial lipopolysaccharides to polymyxin B in an amphiphilic carrier 'sodium deoxycholate sulfate'. Madhumanchi S, Suedee R, Nakpheng T, Tinpun K, Temboot P, Srichana T. Colloids Surf B Biointerfaces; 2019 Oct 01; 182():110374. PubMed ID: 31330430 [Abstract] [Full Text] [Related]
16. Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(varepsilon-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B. Falamarzian A, Lavasanifar A. Colloids Surf B Biointerfaces; 2010 Nov 01; 81(1):313-20. PubMed ID: 20674292 [Abstract] [Full Text] [Related]
17. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain. Shao K, Huang R, Li J, Han L, Ye L, Lou J, Jiang C. J Control Release; 2010 Oct 01; 147(1):118-26. PubMed ID: 20609375 [Abstract] [Full Text] [Related]
18. Engineering Oral and Parenteral Amorphous Amphotericin B Formulations against Experimental Trypanosoma cruzi Infections. Rolón M, Serrano DR, Lalatsa A, de Pablo E, Torrado JJ, Ballesteros MP, Healy AM, Vega C, Coronel C, Bolás-Fernández F, Dea-Ayuela MA. Mol Pharm; 2017 Apr 03; 14(4):1095-1106. PubMed ID: 28198632 [Abstract] [Full Text] [Related]
19. Polymeric micelles for drug delivery: solubilization and haemolytic activity of amphotericin B. Yu BG, Okano T, Kataoka K, Kwon G. J Control Release; 1998 Apr 30; 53(1-3):131-6. PubMed ID: 9741920 [Abstract] [Full Text] [Related]